Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 499 entries
View as:

Docetaxel in Treating Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003565 Org: User:
Start: 09/30/98 End: 01/31/08 Due: 01/31/09

Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05677373 Org: User:
Start: 01/13/23 End: 07/31/25 Due: 07/31/26

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00516217 Org: User:
Start: 06/30/08 End: 02/28/15 Due: 02/28/16

Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane

Phase: N/A Priority: Normal
NCT ID: NCT00059852 Org: User:
Start: 06/30/03 End: 01/31/09 Due: 01/31/10

Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01294280 Org: User:
Start: 07/31/08 End: 02/02/16 Due: 02/02/17

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00489411 Org: User:
Start: 04/30/08 End: 03/31/13 Due: 03/31/14

Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002760 Org: User:
Start: 08/31/96 End: 04/30/09 Due: 04/30/10

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00077311 Org: User:
Start: 08/31/04 End: 04/30/09 Due: 04/30/10

Citalopram in Treating Postmenopausal Women With Hot Flashes

Phase: N/A Priority: Normal
NCT ID: NCT00363909 Org: User:
Start: 11/30/06 End: 12/31/10 Due: 12/31/11

Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005829 Org: User:
Start: 02/29/00 End: 04/30/08 Due: 04/30/09

Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831

Phase: N/A Priority: Normal
NCT ID: NCT00898898 Org: User:
Start: 05/31/00 End: 04/30/19 Due: 04/30/20

DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701

Phase: N/A Priority: Normal
NCT ID: NCT01057459 Org: User:
Start: 02/28/10 End: 06/23/14 Due: 06/23/15

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003834 Org: User:
Start: 03/31/99 End: 12/31/05 Due: 12/31/06

Everolimus in Treating Patients With Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00098553 Org: User:
Start: 04/30/05 End: 02/28/10 Due: 02/28/11

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

Phase: N/A Priority: Normal
NCT ID: NCT00316836 Org: User:
Start: 04/30/06 End: 02/29/12 Due: 02/28/13

Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006349 Org: User:
Start: 02/28/01 End: 01/31/07 Due: 01/31/08

Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase: N/A Priority: Normal
NCT ID: NCT00938470 Org: User:
Start: 01/31/10 End: 03/31/18 Due: 03/31/19

Creatine in Treating Patients With Cancer-Associated Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT00081250 Org: User:
Start: 12/31/04 End: 07/31/17 Due: 07/31/18

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00377156 Org: User:
Start: 07/31/06 End: 12/15/19 Due: 12/15/20

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00053885 Org: User:
Start: 07/31/03 End: 06/30/06 Due: 06/30/07

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05710406 Org: User:
Start: 08/16/23 End: 06/01/34 Due: 06/01/35

Axillary Reverse Mapping in Preventing Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection

Phase: N/A Priority: Normal
NCT ID: NCT03927027 Org: User:
Start: 07/29/19 End: 01/31/27 Due: 01/31/28

Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00003849 Org: User:
Start: 07/31/99 End: 02/29/08 Due: 02/28/09

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003612 Org: User:
Start: 04/30/99 End: 03/15/19 Due: 03/15/20

Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01139944 Org: User:
Start: 07/31/10 End: 01/31/14 Due: 01/31/15